https://www.selleckchem.com/pr....oducts/Semagacestat(
To compare the efficacy and safety of subthreshold micropulse laser treatment (SML), standard-fluence photodynamic therapy (PDT) and low-fluence PDT in patients with chronic central serous chorioretinopathy (cCSC). This retrospective study included 52 eyes of 46 patients with chronic CSC who were treated with 577nm SML (n=23), standard-fluence PDT (verteporfin 6mg/m and light energy 50J/cm ) (n=13), or low-fluence PDT (verteporfin 6mg/m and light energy 25J/cm ) (n=16). The mean changes in best-corrected visual acuity (BC
Respect!
Kommentar
Delen
